Newly Launched Biotech to Develop Lung-specific Gene Therapy Vectors
A newly launched biotech company called Carbon Biosciences is aiming to develop lung-specific gene therapy vectors — vehicles to deliver genetic material directly into a cell — to help treat cystic fibrosis (CF). The company has $38 million in series A financing, funded in part by the Cystic…